Core Viewpoint - The article discusses the development of a robust computational framework called MAPLE for predicting methylation age and disease risk, which addresses the limitations of traditional epigenetic clocks and has significant potential for clinical applications in aging and health management [3][4][26]. Group 1: Background and Need for MAPLE - Aging is characterized by increased morbidity and declining quality of life, creating significant social and economic burdens [2]. - Breakthrough research indicates that interventions like caloric restriction and epigenetic reprogramming can extend lifespan and healthspan, but precise quantification of biological age and aging rate is necessary for clinical application [2]. - DNA methylation (DNAm) changes are key markers of aging, with whole-genome DNAm serving as a potential biological age assessment tool [2]. Group 2: MAPLE Development and Performance - MAPLE employs pairwise learning to determine the relative relationship between two DNA methylation profiles regarding age or disease risk, effectively reducing technical biases while identifying biological signals related to aging or disease [4][9]. - In 31 benchmark tests, MAPLE achieved a median absolute error of 1.6 years, outperforming five other competitive methods [4][12]. - MAPLE demonstrated excellent performance in disease risk assessment, with an average area under the curve (AUC) of 0.97 for disease identification and 0.85 for pre-disease state detection [4][19]. Group 3: Advantages of MAPLE - Traditional epigenetic clocks face challenges such as batch effects, which significantly hinder their clinical application [7][26]. - MAPLE's innovative approach focuses on relative relationships rather than absolute predictions, allowing for better comparability across diverse datasets [9][26]. - The two-stage training process of MAPLE enhances sample size and reduces overfitting risks, contributing to its superior performance [9][12]. Group 4: Clinical Applications and Future Prospects - MAPLE not only accurately predicts biological age but also serves as a health risk warning system, providing valuable time for early intervention [20][28]. - The framework is expected to play a crucial role in personalized anti-aging interventions, early disease risk screening, and understanding the biological mechanisms of aging [28]. - As MAPLE continues to be validated, it may become a standard component of health assessments, aiding in the management of healthy aging and offering new hope for age-related health challenges [28].

Core Viewpoint - The article discusses a groundbreaking research study that introduces a large language model (LLM)-based biological age prediction method, which estimates overall and organ-specific aging through health examination reports, aiming to enhance health management for the general public [3][4][5]. Group 1: Research Background and Importance - Accurately assessing an individual's aging level is crucial for identifying health risks and preventing age-related diseases, yet current aging indicators face methodological limitations and lack broad applicability [2][8]. - Aging is a major risk factor for mortality and chronic diseases, contributing significantly to societal health burdens, and understanding both overall and organ-specific aging is essential for comprehensive health assessments [7]. Group 2: Methodology and Framework - The research team developed a novel framework that converts health examination data (e.g., blood pressure, liver function) into textual reports for input into a large language model (e.g., Llama3), which analyzes numerous indicators to produce two key outputs: overall biological age and organ-specific ages for six major organs [10][11]. - The LLM does not rely on preset formulas but utilizes a pre-trained medical knowledge base to intelligently infer aging metrics based on individual health details [12]. Group 3: Validation and Results - The study validated its predictive framework using data from over 10 million individuals across six major databases, achieving impressive accuracy rates: 75.7% for predicting all-cause mortality risk, 70.9% for coronary heart disease risk, and 81.2% for liver cirrhosis risk, outperforming traditional models [15][20]. - The age difference predicted by the LLM correlates with increased health risks, with each additional year in predicted age raising all-cause mortality risk by 5.5% and coronary heart disease risk by 7.2% [16]. Group 4: Clinical Applications and Innovations - The research introduces a disease radar warning system, revealing that an increase in cardiovascular age difference correlates with a 45% increase in coronary heart disease risk, while liver age difference correlates with a 63% increase in liver cirrhosis risk [19]. - The study identifies 322 key proteins as potential "aging accelerators," with 56.7% being new targets linked to mortality risk, highlighting the predictive power of the LLM in personalized health management [19]. - By analyzing three years of continuous health examination data, the LLM can generate individual aging rate curves, improving disease outbreak predictions by three times compared to single examination assessments [19].